Three days of evidence-driven dialogue bring the builders, funders, and health systems shaping AI, access, and outcomes together in New York City this December
Partnership aims to demonstrate how clinically validated digital therapeutics can augment and leverage scarce clinician resources for payers, providers, health systems, pharma manufacturers, and employers, as mental health care demand far outpaces clinician capacity
Prospective real-world evidence study will test whether AI-powered pregnancy monitoring catches danger earlier — and build the clinical and economic case for a pilot-to-payment pathway.
BlueprintNav, an oncology patient navigation technology company, has closed its pre-seed round at $777,500 — exceeding its original $750,000 target — and secured a $50,000 Proof of Commercialization Award from the Iowa Economic Development Authority, bringing total early-stage funding to $827,500.
Project Connect will fast-track U.S. adoption of Medical AI’s deep-learning “digital biomarker” technology — bringing cardiologist-grade risk detection to the nearly half of U.S. counties without a single cardiologist
HITLAB will lead an independent real-world evidence study of MyCareGorithm's visual oncology consultation platform, measuring its impact on patient understanding, shared decision-making, and care team workflow
